Viewing Study NCT02714595


Ignite Creation Date: 2025-12-24 @ 1:16 PM
Ignite Modification Date: 2025-12-27 @ 9:53 PM
Study NCT ID: NCT02714595
Status: COMPLETED
Last Update Posted: 2021-01-12
First Post: 2016-02-26
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens
Sponsor: Shionogi
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2016-09-07
Start Date Type: ACTUAL
Primary Completion Date: 2019-04-01
Primary Completion Date Type: ACTUAL
Completion Date: 2019-04-22
Completion Date Type: ACTUAL
First Submit Date: 2016-02-26
First Submit QC Date: None
Study First Post Date: 2016-03-21
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2020-10-21
Results First Submit QC Date: None
Results First Post Date: 2020-12-17
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2020-04-01
Disp First Post Date Type: ACTUAL
Last Update Submit Date: 2020-12-18
Last Update Post Date: 2021-01-12
Last Update Post Date Type: ACTUAL